David M. Dorfman

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma”.

Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma

Cancer Research(2024)10.1158/0008-5472.can-24-1440

N/A

0.386DataRank · unranked

7 citations

Kendell Clement, Jean-Baptiste Alberge, Romanos Sklavenitis‐Pistofidis, Rohan Kodgule, Charles P. Fulco +9 more

Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia

International Journal of Cancer(2022)10.1002/ijc.34405

N/A

0DataRank · unranked

9 citations

Gábor Beke, Zachary R. Hunter, Teru Hideshima, Ludmila M. Flores, Tatiana Zeleznikova +10 more

Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma

Leukemia(2022)10.1038/s41375-022-01588-z

N/A

0DataRank · unranked

0 citations

Shruti Bhatt, Kenneth Wen, Zuzana Chyra, Geoffrey Fell, Yu‐Tzu Tai +7 more

Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma

JCI Insight(2023)10.1172/jci.insight.159924

N/A

0DataRank · unranked

15 citations

Dana Cholujová, Gábor Beke, Teru Hideshima, Lubos Klucar, Merav Leiba +6 more

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

Blood Cancer Journal(2023)10.1038/s41408-023-00791-0

N/A

0DataRank · unranked

3 citations

Zuzana Chyra, Sigitas Verselis, Morgan O'Keefe, Jacquelyn Cobb, Ivane Abiatari +10 more